| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| Ahcyl1 | Bcl2l10 | ENSRNOP00000072856 | ENSRNOP00000012409 | S-adenosylhomocysteine hydrolase-like protein 1; Multifaceted cellular regulator which coordinates several essential cellular functions including regulation of epithelial HCO3(-) and fluid secretion, mRNA processing and DNA replication. Regulates ITPR1 sensitivity to inositol 1,4,5-trisphosphate competing for the common binding site and acting as endogenous 'pseudoligand' whose inhibitory activity can be modulated by its phosphorylation status. In the pancreatic and salivary ducts, at resting state, attenuates inositol 1,4,5-trisphosphate-induced calcium release by interacting with ITP [...] | Bcl-2-like protein 10; Promotes cell survival. Suppresses apoptosis (By similarity). Belongs to the Bcl-2 family. | 0.663 |
| Bad | Bak1 | ENSRNOP00000028712 | ENSRNOP00000000576 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | BCL2-antagonist/killer 1, isoform CRA_b. | 0.809 |
| Bad | Bcl2 | ENSRNOP00000028712 | ENSRNOP00000003768 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | 0.995 |
| Bad | Bcl2a1 | ENSRNOP00000028712 | ENSRNOP00000038537 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | B-cell leukemia/lymphoma 2 related protein A1. | 0.635 |
| Bad | Bcl2l10 | ENSRNOP00000028712 | ENSRNOP00000012409 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | Bcl-2-like protein 10; Promotes cell survival. Suppresses apoptosis (By similarity). Belongs to the Bcl-2 family. | 0.739 |
| Bad | Bcl2l11 | ENSRNOP00000028712 | ENSRNOP00000039006 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | Bcl-2-like protein 11; Induces apoptosis and anoikis. | 0.888 |
| Bad | Bid | ENSRNOP00000028712 | ENSRNOP00000016776 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | BH3-interacting domain death agonist p11; Induces caspases and apoptosis. Counters the protective effect of Bcl-2. The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). | 0.696 |
| Bad | Pmaip1 | ENSRNOP00000028712 | ENSRNOP00000025361 | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | Phorbol-12-myristate-13-acetate-induced protein 1; Promotes activation of caspases and apoptosis. Promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. Contributes to p53/TP53-dependent apoptosis after radiation exposure. Promotes proteasomal degradation of MCL1. Competes with BAK1 and with BIM/BCL2L11 for binding to MCL1; can displace BAK1 and BIM/BCL2L11 from their binding sites (By similarity). Belongs to the PMAIP1 family. | 0.439 |
| Bak1 | Bad | ENSRNOP00000000576 | ENSRNOP00000028712 | BCL2-antagonist/killer 1, isoform CRA_b. | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | 0.809 |
| Bak1 | Bcl2 | ENSRNOP00000000576 | ENSRNOP00000003768 | BCL2-antagonist/killer 1, isoform CRA_b. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | 0.995 |
| Bak1 | Bcl2a1 | ENSRNOP00000000576 | ENSRNOP00000038537 | BCL2-antagonist/killer 1, isoform CRA_b. | B-cell leukemia/lymphoma 2 related protein A1. | 0.990 |
| Bak1 | Bcl2l10 | ENSRNOP00000000576 | ENSRNOP00000012409 | BCL2-antagonist/killer 1, isoform CRA_b. | Bcl-2-like protein 10; Promotes cell survival. Suppresses apoptosis (By similarity). Belongs to the Bcl-2 family. | 0.571 |
| Bak1 | Bcl2l11 | ENSRNOP00000000576 | ENSRNOP00000039006 | BCL2-antagonist/killer 1, isoform CRA_b. | Bcl-2-like protein 11; Induces apoptosis and anoikis. | 0.975 |
| Bak1 | Bid | ENSRNOP00000000576 | ENSRNOP00000016776 | BCL2-antagonist/killer 1, isoform CRA_b. | BH3-interacting domain death agonist p11; Induces caspases and apoptosis. Counters the protective effect of Bcl-2. The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). | 0.993 |
| Bak1 | Bik | ENSRNOP00000000576 | ENSRNOP00000013977 | BCL2-antagonist/killer 1, isoform CRA_b. | Bcl2-interacting killer, isoform CRA_a. | 0.880 |
| Bak1 | Pmaip1 | ENSRNOP00000000576 | ENSRNOP00000025361 | BCL2-antagonist/killer 1, isoform CRA_b. | Phorbol-12-myristate-13-acetate-induced protein 1; Promotes activation of caspases and apoptosis. Promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. Contributes to p53/TP53-dependent apoptosis after radiation exposure. Promotes proteasomal degradation of MCL1. Competes with BAK1 and with BIM/BCL2L11 for binding to MCL1; can displace BAK1 and BIM/BCL2L11 from their binding sites (By similarity). Belongs to the PMAIP1 family. | 0.912 |
| Bcl2 | Bad | ENSRNOP00000003768 | ENSRNOP00000028712 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | Bcl2-associated agonist of cell death; Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. | 0.995 |
| Bcl2 | Bak1 | ENSRNOP00000003768 | ENSRNOP00000000576 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | BCL2-antagonist/killer 1, isoform CRA_b. | 0.995 |
| Bcl2 | Bcl2l10 | ENSRNOP00000003768 | ENSRNOP00000012409 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | Bcl-2-like protein 10; Promotes cell survival. Suppresses apoptosis (By similarity). Belongs to the Bcl-2 family. | 0.582 |
| Bcl2 | Bcl2l11 | ENSRNOP00000003768 | ENSRNOP00000039006 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). Belongs to the Bcl-2 family. | Bcl-2-like protein 11; Induces apoptosis and anoikis. | 0.999 |